ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 681645 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 681645; 2) Community: the network communities that were significantly associated with the response to NSC 681645; 3) Molecule: the relationships between components within communities and NSC 681645; 4) MDR: the compounds that were significantly associated with the NSC 681645.

NSC Compound Enrichment Correlation
NSC 761980 Null 0.0459335986102865 0.034763006
NSC 763646 (E)-2-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-5-(3-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazole 0.0459335986102865 0.10014274
NSC 92504 Null 0.0459335986102865 0.033201187
NSC 682996 Null 0.0474314077111075 0.31215269
NSC 743433 8-(4-{4-[6-(4-piperazinoquinazoline)-7-methoxy-2,3,5,11-atetrahydra-1H-benzo[e]pyrrolo[1,2-c][1,4]diazepin-5-one 0.0474314077111075 0.21945712
NSC 106246 Null 0.0474314077111082 0.0035868402
NSC 106554 Musennin 0.048939380959983 0.083485214
NSC 172614 9H-Purin-2-amine, 9-(2-deoxy-.beta.-D-erythro-pentofuranosyl)-6-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]- 0.048939380959983 0.214453
NSC 19441 FDA 0283 0.048939380959983 0.35655722
NSC 268665 Null 0.048939380959983 0.39181232
Total:67  Current:64    [First] [Prev] [Next] [Last]